0001209191-21-046700.txt : 20210714
0001209191-21-046700.hdr.sgml : 20210714
20210714184758
ACCESSION NUMBER: 0001209191-21-046700
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210712
FILED AS OF DATE: 20210714
DATE AS OF CHANGE: 20210714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crockett Nigel
CENTRAL INDEX KEY: 0001788580
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 211091267
MAIL ADDRESS:
STREET 1: C/O BICYCLE THERAPEUTICS PLC
STREET 2: B900, BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-12
0
0001761612
BICYCLE THERAPEUTICS plc
BCYC
0001788580
Crockett Nigel
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
0
1
0
0
Chief Business Officer
Ordinary Shares
2021-07-12
4
M
0
4331
11.66
A
4331
D
Ordinary Shares
2021-07-12
4
M
0
1723
9.82
A
6054
D
Ordinary Shares
2021-07-12
4
M
0
974
15.36
A
7028
D
Ordinary Shares
2021-07-12
4
S
0
7028
32.03
D
0
D
Ordinary Shares
2021-07-13
4
M
0
40426
11.66
A
40426
D
Ordinary Shares
2021-07-13
4
M
0
19256
9.82
A
59682
D
Ordinary Shares
2021-07-13
4
M
0
13019
15.36
A
72701
D
Ordinary Shares
2021-07-13
4
S
0
69580
32.41
D
3121
D
Ordinary Shares
2021-07-13
4
S
0
3121
33.09
D
0
D
Employee Stock Option (right to buy)
11.66
2021-07-12
4
M
0
4331
0.00
D
2029-09-26
Ordinary Shares
4331
103086
D
Employee Stock Option (right to buy)
9.82
2021-07-12
4
M
0
1723
0.00
D
2030-01-02
Ordinary Shares
1723
58006
D
Employee Stock Option (right to buy)
15.36
2021-07-12
4
M
0
974
0.00
D
2030-02-21
Ordinary Shares
974
43783
D
Employee Stock Option (right to buy)
11.66
2021-07-13
4
M
0
40426
0.00
D
2029-09-26
Ordinary Shares
40426
62660
D
Employee Stock Option (right to buy)
9.82
2021-07-13
4
M
0
19256
0.00
D
2030-01-02
Ordinary Shares
19256
38750
D
Employee Stock Option (right to buy)
15.36
2021-07-13
4
M
0
13019
0.00
D
2030-02-21
Ordinary Shares
13019
30764
D
Shares sold pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.99 inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50 inclusive.
25% of the shares underlying this option shall vest on September 26, 2020, and the remaining shall vest in 36 equal monthly installments.
This option shall vest one-fourth (1/4) of the total number of shares under option on January 2, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter.
This option shall vest one-fourth (1/4) of the total number of shares under option on February 21, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter.
/s/ Lee Kalowski, Attorney-in-Fact
2021-07-14